Skip to main content

Semi-solid Extrusion 3D Printing for the Development of Dosage Forms for Special Patient Groups

Part of the Advanced Clinical Pharmacy - Research, Development and Practical Applications book series (ACPRDPA,volume 2)

Abstract

The current availability of dosage forms for patients with special requirements, such as pediatrics, is low while often leading to poor acceptability and inadequate treatment adherence. As a result, unlicensed and off-labeled preparations are common, exposing patients to unpredictable risks. During the last years, there is an obvious momentum for drug development tailored to such patient groups, with 3D printing being at the forefront of research in this area. In this context, semi-solid extrusion 3D printing, with the unique capability of additive manufacturing without requiring extreme temperatures, is paving the way toward personalized medicine, point-of-care fabrication upon demand, and digitalization of the pharmaceutical industry.

Keywords

  • 3D printing
  • Semi-solid extrusion
  • Personalized medicine
  • Special groups
  • Patient compliance

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

3DP:

Three-dimensional Printing

API:

Active Pharmaceutical Ingredient

CAD:

Computer-Aided Design

CMC:

Carboxymethylcellulose

FDA:

Food and Drug Administration

FDM:

Fused Deposition Modelling

HPC:

Hydroxypropyl Cellulose

HPMC:

Hydroxypropyl Methylcellulose

LEV:

Levetiracetam

MSUD:

Maple Syrup Urine Disease

ODF:

Orodispersible Film

ODT:

Orodispersible Tablet

PLGA:

Poly Lactic-co-Glycolic Acid

PS:

Pregelatinized Starch

PVA:

Polyvinyl Alcohol

PVP:

Polyvinyl Pyrrolidone

QbD:

Quality by Design

SPG:

Special Patient Group

SSE:

Semi-Solid Extrusion

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dimitrios G. Fatouros .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gkaragkounis, A., Fatouros, D.G. (2023). Semi-solid Extrusion 3D Printing for the Development of Dosage Forms for Special Patient Groups. In: Lamprou, D. (eds) Nano- and Microfabrication Techniques in Drug Delivery . Advanced Clinical Pharmacy - Research, Development and Practical Applications, vol 2. Springer, Cham. https://doi.org/10.1007/978-3-031-26908-0_6

Download citation